Susquehanna International Group, LLP Crinetics Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $568 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 07, 2024
SELL
$34.76 - $46.81 $3.03 Million - $4.09 Million
-87,300 Reduced 33.13%
176,200 $8.25 Million
Q4 2023

Feb 14, 2024
BUY
$25.62 - $37.07 $3.64 Million - $5.26 Million
142,000 Added 116.87%
263,500 $9.38 Million
Q3 2023

Nov 14, 2023
BUY
$15.97 - $30.59 $1.94 Million - $3.72 Million
121,500 New
121,500 $3.61 Million

Others Institutions Holding CRNX

# of Institutions
221
Shares Held
75.8M
Call Options Held
631K
Put Options Held
749K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.45B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email